Insider trades
Benjamin Cravatt, Director of Alnylam Pharmaceuticals ALNY, has filed 0 purchases and 2 sales on the open market. The latest trade was on 06/01.
Benjamin Cravatt
Director
- Company
- Alnylam Pharmaceuticals ALNY
- First filing
- 23/06/09
- Trades
- 6 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- No record
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
KYNB | Open-market sale10b5-1 plan | 23/06/09 | 23/06/09 | 3,944 sh2 trades | $17.17avg. | $67,717.28 | −12.1% |
